Too much formation of uric acid can cause a gout flare-up, resulting in pain, swelling, and redness of the joint.

Find effective medications for 'Gout treatment right here!' This page is a trusted source for both professionals and patients, detailing brand-name and generic options designed to manage Gout.

Treatment for gout may include reducing your consumption of these offending foods. While it might be surprising to you, ...

For gout, xanthine oxidase (XO) inhibitors are the choice for first-line urate-lowering therapy (ULT) according to the 2020 American College of Rheumatology Guideline for the Management of Gout ...

ABP-671 is a class 1 innovative chemotherapeutic drug for the treatment of gout and hyperuricemia, currently in Phase 2b/3 clinical trials for gout in China and overseas. The Product reduces renal ...

XORTX to focus on late stage allopurinol intolerant gout program; discussion with FDA planned for first half 2025 regarding ...

XORTX Therapeutics (XRTX) announces the launch of a new late stage program to treat gout. The new drug development program – XRx-026 – will ...

A new drug called febuxostat has been found to reduce plasma levels of uric acid more effectively in Gout than the currently used drug allopurinol. If the results of the clinical trial are ...

After one to two weeks, the inflammation eventually goes away on its own. If you have gout, talk to your doctor about medications and lifestyle changes that can help.

In the case of a severe attack of gout, you may need to take antiinflammatory drugs prescribed by your GP. These can be very effective, but to gain the best results the drugs must be taken at the ...

Doctor Edward Dwyer knows gout when he sees it ... do we just want to treat the acute attacks or do you want to take a medication to reduce your level of uric acid such that you will no longer ...

Date and FDA Advisory Committee. June 2, 2004 meeting of the Arthritis Advisory Committee. Subject. Clinical trial designs and endpoints for drugs for chronic gout, including new drug application ...